January 27, 2021
The Ministry of Health, Labor and Welfare (MHLW) on January 26 ordered label revisions to add new safety risks for two cancer drugs Pomalyst (pomalidomide) and MabCampath (alemtuzumab) by Celgene and Sanofi. For Pomalyst, the new label will add the...read more